GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 768 filers reported holding GLAXOSMITHKLINE PLC in Q4 2017. The put-call ratio across all filers is 1.35 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $321,000 | -6.7% | 7,377 | -6.5% | 0.02% | +11.1% |
| Q1 2022 | $344,000 | -2.8% | 7,888 | -1.7% | 0.02% | +5.9% |
| Q4 2021 | $354,000 | -10.8% | 8,021 | -22.8% | 0.02% | -15.0% |
| Q3 2021 | $397,000 | +3.7% | 10,388 | -3.3% | 0.02% | 0.0% |
| Q2 2021 | $383,000 | 0.0% | 10,738 | 0.0% | 0.02% | 0.0% |
| Q1 2021 | $383,000 | -6.6% | 10,738 | -3.6% | 0.02% | -9.1% |
| Q4 2020 | $410,000 | -1.7% | 11,143 | +0.5% | 0.02% | -15.4% |
| Q3 2020 | $417,000 | -7.7% | 11,088 | 0.0% | 0.03% | -13.3% |
| Q2 2020 | $452,000 | +19.3% | 11,088 | +10.9% | 0.03% | 0.0% |
| Q1 2020 | $379,000 | -22.5% | 10,000 | -3.8% | 0.03% | 0.0% |
| Q4 2019 | $489,000 | +2.9% | 10,400 | -6.5% | 0.03% | -3.2% |
| Q3 2019 | $475,000 | +10.5% | 11,121 | +3.5% | 0.03% | +10.7% |
| Q2 2019 | $430,000 | -42.7% | 10,746 | -40.1% | 0.03% | -45.1% |
| Q1 2019 | $750,000 | +9.5% | 17,946 | 0.0% | 0.05% | -1.9% |
| Q4 2018 | $685,000 | -5.0% | 17,946 | 0.0% | 0.05% | +30.0% |
| Q3 2018 | $721,000 | -4.0% | 17,946 | -3.7% | 0.04% | -9.1% |
| Q2 2018 | $751,000 | +7.1% | 18,636 | +3.8% | 0.04% | +4.8% |
| Q1 2018 | $701,000 | +8.3% | 17,946 | -1.6% | 0.04% | +10.5% |
| Q4 2017 | $647,000 | -12.7% | 18,246 | 0.0% | 0.04% | -15.6% |
| Q3 2017 | $741,000 | -10.4% | 18,246 | -4.9% | 0.04% | -13.5% |
| Q2 2017 | $827,000 | +2.6% | 19,177 | +0.3% | 0.05% | +6.1% |
| Q1 2017 | $806,000 | -3.7% | 19,120 | -12.1% | 0.05% | -5.8% |
| Q4 2016 | $837,000 | -10.8% | 21,746 | 0.0% | 0.05% | -24.6% |
| Q3 2016 | $938,000 | -0.5% | 21,746 | 0.0% | 0.07% | -1.4% |
| Q2 2016 | $943,000 | +4.7% | 21,746 | -2.1% | 0.07% | +4.5% |
| Q1 2016 | $901,000 | -10.9% | 22,212 | -11.4% | 0.07% | -6.9% |
| Q4 2015 | $1,011,000 | -52.4% | 25,064 | -54.6% | 0.07% | -54.1% |
| Q3 2015 | $2,122,000 | -3.2% | 55,206 | +16.2% | 0.16% | +4.0% |
| Q2 2015 | $2,193,000 | 0.0% | 47,510 | 0.0% | 0.15% | 0.0% |
| Q1 2015 | $2,193,000 | +9.4% | 47,510 | +1.2% | 0.15% | +7.9% |
| Q4 2014 | $2,005,000 | +31.9% | 46,928 | +42.0% | 0.14% | +26.1% |
| Q3 2014 | $1,520,000 | -41.7% | 33,055 | -32.2% | 0.11% | -39.7% |
| Q2 2014 | $2,608,000 | +2.1% | 48,781 | +2.0% | 0.18% | -2.1% |
| Q1 2014 | $2,554,000 | +13.1% | 47,806 | +13.0% | 0.19% | +8.7% |
| Q4 2013 | $2,258,000 | +22.1% | 42,299 | +14.8% | 0.17% | +8.1% |
| Q3 2013 | $1,849,000 | +99.0% | 36,857 | +98.2% | 0.16% | +102.5% |
| Q2 2013 | $929,000 | – | 18,600 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| OSTERWEIS CAPITAL MANAGEMENT INC | 1,948,915 | $79,029,000 | 4.59% |
| Chubb Ltd | 400,000 | $16,220,000 | 4.42% |
| Pegasus Partners Ltd. | 172,275 | $6,986,000 | 3.79% |
| Keystone Financial Planning, Inc. | 117,762 | $4,775,000 | 3.42% |
| P.R. Herzig & Co. Inc. | 36,950 | $1,498,000 | 3.28% |
| Sterneck Capital Management, LLC | 112,535 | $4,563,000 | 3.21% |
| Healthcare Value Capital, LLC | 50,000 | $2,028,000 | 2.98% |
| Hamlin Capital Management, LLC | 1,454,031 | $58,961,000 | 2.98% |
| Jolley Asset Management, LLC | 80,639 | $3,270,000 | 2.98% |
| JFB Holdings Corp | 2,415,570 | $97,951,000 | 2.91% |